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Summary. Background: There is no standard practice in the induction of colitis by 2,4,6-trinitrobenzene sul-
fonic (TNBS) acid. Usually, the repeated administration of TNBS is preferred, because it will result in a local 
Th1 response that has the characteristics of Crohn`s disease. Materials and Methods: A total of 30 rats were 
randomized into two groups, consisting of a saline control group of ten rats and a TNBS groups of 20 rats. 
After the animals were anesthetized, 0.5 ml of either 0.9% saline (controls) or TNBS 50 mg/kg dissolved in 
50% ethanol were instilled into the colon through a rubber catheter. The experiment was repeated weekly for 
four weeks, then, the rats were killed at day 40, and the distal colon removed. Results: At day 40, the bowel 
wall was basically normal in the control group. In the TNBS group, the bowel lumen became narrow with 
thickened wall, and the mucosal surface presented adherent membrane with brown black, linear ulcers, prolif-
erous lymphocyte tissue, inflammatory granulomas and submucosal neutrophil infiltration. The median score 
of the severity of the colonic damage was 0 in the control group, and 4,75 (range 4-5) in the TNBS group; 
the mean weight of the rats was 180+35 g in the TNBS group, while it was 215+25 in the control group. Con-
clusions: The presented experiment is a cost-effective and safe method to induce Crohn-like colonic damage 
using a lower dose of TNBS, thus avoiding the risk of a massive loss of rats. This model is rather suitable for 
the assessment of the effects of potential therapeutic agents. (www.actabiomedica.it)
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O r i g i n a l  a r t i c l e
Introduction 
There is no standard practice in the induction of 
colitis by 2,4,6-trinitrobenzene sulfonic (TNBS) acid 
(1). The TNBS-induced colitis can be evaluated de-
veloping three different models: acute, established and 
chronic colitis. These forms are not well documented 
in current practice, and the absence of a standardized 
terminology leads to confusion (1, 2). 
Usually, the repeated administration of TNBS is 
preferred, resulting in a local Th1 response that has the 
characteristics of Crohn’s disease (3, 4). The chronic 
administration of TNBS should result in chronic coli-
tis resembling Crohn`s disease too, but, to date, there is 
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not yet much experience with this model. The chronic 
TNBS-induced colitis (induced by seven weekly in-
trarectal administrations of TNBS in ethanol) most 
likely reflects the chronic phase of Crohn’s disease 
and it is accompanied by the production of IL-23 and 
IL-17 by isolated lamina propria mononuclear cells, 
49 days after initial administration. Recently, this was 
clearly demonstrated by Fichtner-Feigh et al. (2). In 
this model, TNBS needed to be dosed very carefully to 
avoid a massive loss of mice (4, 5). The aim of our study 
is to evaluate the effects of repeated administration of 
TNBS in a sample of Wistar rats (5-7). 
Materials and Methods
For this study, Winstar male rats weighing 
235 g ± 25 g were employed. The animals were housed 
in rack-mounted cages with a maximum of 2 rats, and 
were fasted for 12 hours with access to water ad li-
bitum before the experiment. In this period, together 
with fasting, they underwent bowel cleansing through 
the administration of Poliethylene Glycole 1 g/kg, and, 
one hour before the experiment, through an evacu-
ative enema with 0.9% saline solution. A total of 30 
rats were randomized into two groups, consisting of a 
saline control group of 10 rats and a TNBS groups of 
20 rats. The animals were anesthetized with 20% ethyl 
carbamate (6 ml/kg), and 0.5 ml of either 0.9% saline 
(controls) or TNBS 50 mg/kg dissolved in 50% ethanol 
were instilled into the colon through a rubber catheter 
(12 cm long, external diameter 2 mm). After instilla-
tion, the rats were held upside down by their tails for 
60 seconds and then returned to their cages. The ex-
periment was repeated weekly for four weeks, then the 
rats were killed at day 40, and the distal colon (8 cm) 
removed, opened longitudinally and washed to remove 
luminal contents (Fig. 1). The rats were sacrificed by 
cervical dislocation. The abdominal cavity was opened 
and a gross evaluation of the digestive tract was made, 
following an already consolidated protocol (8). The 
liver and the gastrointestinal tract, intact from anus to 
stomach, were immediately excised. The large intes-
tine was subdivided into colon and rectum, and then 
opened longitudinally and cleaned with saline. Several 
samples were collected for the histological evaluation 
and fixed in a solution of 10% of formalin. The excised 
colon was pinned out on a wax block washed with 0.9% 
saline and assigned to a code number (weight of colon 
segment 8-10 g). The colon was immediately examined 
under a stereomicroscope and any visible damage was 
scored on a 0-5 scale (Table 1), previously evaluated 
in another model. Small sections of colon were taken 
from two distinct areas from each colon and placed in 
10% formalin for histological examination. Each sam-
ple was fixed in formalin and embedded in paraffin. 
Sections with a thickness of 5 μm were obtained from 
paraffin blocks, and were deparaffinised with xylene for 
10 min at 60°C and hydrated with a decreasing etha-
nol gradient. They were stained with haematoxylin for 
4 min (Merck KGaA, Darmstadt, Germany), blocked 
for 15 min in tap water, treated with eosin (Merck 
GgaA) for 1 min and rinsed in water. The sections were 
dehydrated and mounted with a coverslip for histologi-
cal examination using an automated Leica DM5000 
B microscope (Leica, Milan, Italy) connected to a 
Leica DC300 F high-resolution camera (Leica, Milan, 
Italy). All histological evaluations were carried out by 
Figure 1. Sample of a portion of about 15 cm comprising the 
rectum and colon. Macroscopically areas of the inflammation 
site are observed, with increased volume of the lymph nodes 
(circles indicate the lymph nodes, and arrows the areas involved 
by inflammation)
Table 1. Criteria for scoring the gross morphologic damage 
Score Gross morphology: 
0  No damage 
1  Localized hyperemia with no ulcers 
2  Linear ulcers with no significant inflammation 
3  Linear ulcers with inflammation at one site 
4  Multiple sites of ulcers and inflammation, the size of ulcers 
<1 cm 
5  Multiple inflammations and ulcers, the size of ulcers >1 cm
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two different histopathologists on ten random fields at 
200X magnification.
Myeloperoxidase activity was not evaluated. Fur-
thermore, to examine the severity of the colitis, the 
body weight of the treated rats was measured every 
other day, and clinical findings such as area of ulcers 
(measured using NIH imaging software on the colon 
pictures), length (colocaecal junction to anal verge), 
and weight of the colon 10 days after the last TNBS 
injection were also assessed. 
During the experimental period the weight of 
treated rats was decreased due to onset of diarrhea that 
led to intestinal malabsorption while the weight of 
control group remained stable.
Results
Forty days after TNBS/ethanol administration, 
the bowel wall was basically normal in the control 
group (Table 2). In the TNBS group, the bowel lu-
men became narrow with thickened wall (2-3 mm), 
while on the bowel mucosal surface there was an ad-
herent membrane with brown black, linear ulcers (1-6 
mm), proliferating lymphocyte tissue, inflammatory 
granulomas and submucosal neutrophilic infiltration. 
Macrophages, lymphocytes, fibroblasts, and cryptoab-
scesses were also observed. This group also presented 
noticeable ulcers and inflammatory granulomas in the 
colon; neutrophil infiltration was clearly observed in 
mucosa and sub-mucosa, and extensive necrosis of the 
colonic mucosa with exfoliation of the epithelia were 
found in the other rats with intact muscularis. In the 
case of severe ulcers, the colon often adhered to the 
surrounding intestinal tissues and abdominal wall 
(Figg. 1-4). 2 rats of TNBS groups died for diarrheal 
syndrome and cachexia after the second and the fourth 
day of treatment. 
 At the end of the experiment, the median score of 
the severity of the colonic damage was 0 in the control 
group, and 4.75 (range 4-5) in the TNBS group; the 
mean weight of the rats was 180+35 g in the TNBS 
group, while it was 215+25 in the control group.
Table 2
 T T0 T1 T2 T3
   (after 3 days) (after 7 days) (after 30 days)
 Clinical  absent Diarrhea* Bloody mucus Bloody mucus
 features   diarrhea and  diarrhea and
    weight loss weight loss
*Death of one rat on the second and fourth day of treatment
Figure 2. Histologically, in the tract of the rectum examined 
an inflammatory infiltrate is observed, consisting of monocyte 
cells (lymphocytes, macrophages, plasma cells) and some neu-
trophils, involving the mucosa and submucosa up to the tunica 
muscularis. Furthermore, there are observed areas of loss of the 
epithelial lining that reaches the muscularis (ulcers), in which 
the inflammatory infiltrate is more pronounced
Figure 3. Histologically, in the tract of the rectum examined 
an inflammatory infiltrate is observed, consisting of monocyte 
cells (lymphocytes, macrophages, plasma cells) and some neu-
trophils, involving the mucosa and submucosa up to the tunica 
muscularis. Furthermore, there are observed areas of loss of the 
epithelial lining that reaches the muscularis (ulcers), in which 
the inflammatory infiltrate is more pronounced
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Discussion
Our method for the induction of colitis in rats 
involves the use of 50 mg TNBS dissolved in 50% 
ethanol, a low dose which has proven to be able of 
causing a diffuse colonic inflammation, characterized 
by increased leukocyte infiltration, edema, and ulcera-
tion. This method based on a repeated administration 
of TNBS is developed because it will result in a local 
Th1 response that has characteristics of Crohn`s dis-
ease. Furthermore, this dosage is chosen to avoid mas-
sive loss of rats as published also by other researchers 
reporting the use of similar doses (9, 10).
The experimental model used is a well-validated 
animal model, simple, reproducible, and adaptable to 
small animals. Over years, the development of the 
model of colitis by TNBS (as well as the development 
of other experimental models of intestinal inflamma-
tion) has allowed a very close study of early events, the 
analysis of the interactions between the different com-
ponents and the identification of the immunological 
and genetic processes that determine susceptibility (3, 
4). This model has provided important informations 
about the mechanisms underlying inflammation and 
pathogenesis as well as the treatment of inflammatory 
bowel diseases. The main objective of our study was 
to develop a model of chronic colitis by TNBS in the 
rat, to reproduce the clinical course of human chronic 
inflammatory bowel diseases, usually characterized by 
periods of active inflammation interspersed with more 
or less long remissions, and subsequently, in a second 
step, to evaluate the therapeutic effect of fat-derived 
mesenchymal stem cells (FD-MSC) on the reactiva-
tion of colitis (11-13). To develop this model of TN-
BS-induced chronic colitis, we studied the effect of 
repeated instillation of the hapten on reactivation of 
the inflammatory process and the course of inflamma-
tion during the four-week duration of the experiment. 
The results showed that the repeated dose of TNBS 
induces a recurrence of the phenomenon inflammato-
ry, with the appearance of ulcers in the colon, infiltra-
tion of granulocytes in the mucosa and submucosa and 
diarrhea in the treated group. 2 rats of this group died 
for diarrheal syndrome and cachexia after the second 
and the fourth day of treatment.The administration of 
TNBS in the model determines an increase in tissue 
levels of TNF-α and myeloperoxidase activity, and, 
consequently, is characterized by the presence of a sig-
nificant inflammatory infiltrate (5), as demonstrated 
by histological analysis.
Conclusions
TNBS is a hapten which, when it is bound with 
tissue proteins, will turn into a antigen. It has been 
shown that it can elicit immunological responses, thus 
inducing generation of colitis (6, 7). 
The TBNS model is widely used for the study 
of the immunological mechanism that have a role in 
the pathogenesis of IBD since it is easily induced and 
highly reproducible.
This model is characterized by a simple process, 
reproducibility of the colonic damage, and inexpensive 
and short duration of the experiment, thus obtaining 
long-lasting damage with inflammatory cell infiltra-
tion and ulcers. Thus the model is rather suitable for 
the assessment of the effects of potential therapeutic 
agents and it would be suitable for new regenerative 
therapies with adult stem cell.
In the present study, the dose of TNBS producing 
a moderate colonic inflammation and ulcers was about 
50 mg/kg. The advantage of this model is that Crohn-
like colonic damage was obtained using a lower dose 
of TNBS, thus avoiding the risk of a massive loss of 
Figure 4. In the lymph node there is a hyperplastic lymphad-
enitis, with evidence of lymph corpuscles, the outcome of the 
insult to the rectum
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rats. Forthcoming studies are needed to evaluate the 
cytokine profile in this model.
References 
1.  te Velde A, Verstege MI, Hommes DW. Critical Appraisal 
of the Current Practice in Murine TNBS-induced Colitis. 
Inflamm Bowel Dis 2006; 12: 995-9.
2.  Fichtner-Feigl S, Fuss IJ, Preiss JC, et al. Treatment of mu-
rine Th1- and Th2-mediated inflammatory bowel disease 
with NK-kappa B decoy oligonucleotides. J Clin Invest 2005; 
115: 3057Y3071.
3.  Zheng L, Gao QG, Wang SX. A chronic ulcerative colitis 
model in rats. World J Gastroenterol 2000; 6: 150-2.
4.  Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experi-
mental models of inflammatory bowel disease. Gastroenter-
ology 1995; 109: 1344-67.
5.  Boughton-Smith NK, Wallace JL, Whittle BJ. Relationship 
between arachidonic acid metabolism, myeloperoxidase ac-
tivity and leukocyte infiltration in a rat model of inflamma-
tory bowel disease. Agents Actions 1988; 25: 115-23.
6.  Little JR, Eisen HN. Preparation and characterization of 
antibodies specific for the 2, 4, 6 trinitrophenyl group. Bio-
chemistry 1966; 5: 3385-95.
7.  Fidler JM. Induction of hapten-specific immunological toler-
ance and immunity in B lymphocytes. Correlation between 
trinitrobenzenesulfonic acid administration, serum trinitro-
phenyl content, and level of tolerance. Cell Immunol 1985; 
94: 285-91. 
8.  Bellavia M, Rappa F, Lo Bello M, Brecchia G, Tomasello G, 
Leone A, Spatola G, Uzzo ML, Bonaventura G, David S, 
Damiani P, Hajj Hussein I, Zeenny MN, Jurjus A, Schembri-
Wismayer P, Cocchi M, Zummo G, Farina F, Gerbino A, 
Cappello F, Traina G. Lactobacillus casei and bifidobacte-
rium lactis supplementation reduces tissue damage of intesti-
nal mucosa and liver after 2,4,6-trinitrobenzenesulfonic acid 
   treatment in mice. J Biol Regul Homeost Agents 2014; 28 
(2): 251-61.
  9.  Ocón B, Anzola A, Ortega-González M, Zarzuelo A, 
Suárez MD, Sánchez de Medina F, Martínez-Augustin O. 
Active hexose-correlated compound and Bifidobacterium 
longum BB536 exert symbiotic effects in experimental coli-
tis Eur J Nutr  2013; 52 (2): 457-66.
10.  Martínez-Augustin O, López-Posadas R, González R, 
Suárez MD, Zarzuelo A, Sánchez de Medina F. Genomic 
analysis of sulfasalazine effect in experimental colitis is con-
sistent primarily with the modulation of NF-kappaB but 
not PPAR-gamma signaling Pharmacogenet Genomics 
2009; 19 (5): 363-72.
11.  Bellavia M, Altomare R, Cacciabaudo F, Santoro A, Allegra 
A, Concetta Gioviale M, Lo Monte AI. Towards an ideal 
source of mesenchymal stem cell isolation for possible ther-
apeutic application in regenerative medicine. Biomed Pap 
Med Fac Univ Palacky Olomouc Czech Repub 2013 Jul 29. 
doi: 10.5507/bp.2013.051. [Epub ahead of print]
12.  Allegra A, Altomare R, Curcio P, Santoro A, Lo Monte 
AI, Mazzola S, Marino A. Gene expression of stem cells at 
different stages of ontological human development. Eur J 
Obstet Gynecol Reprod Biol 2013; 170 (2): 381-6. 
13.  Gioviale MC, Bellavia M, Damiano G, Lo Monte AI. Be-
yond islet transplantation in diabetes cell  therapy: from em-
bryonic cells to transdifferentation of adult cells. Transplant 
Proc 2013; 45 (5): 2019-24. 
Received: 18 July 2014
Accepetd: 15 September 2014
Correspondance:
Prof. Giovanni Tomasello
“DICHIRONS”, Dep. of Surgical, Oncological
and Stomatological Disciplines
University of Palermo, Italy
E-mail: giovanni.tomasello@unipa.it
